News
Boston Scientific Announces Its Schedule for Heart Rhythm Society...
news.bostonscientific.com
Vivek Y. Reddy, M.D., Petr Neuzil, M.D., Gerhard Schuler, M.D., Sven Mobius-Winkler, M.D., Peter Sick, M.D., and Horst Sievert, M.D., will present preliminary ...
History of Changes for Study: NCT
clinicaltrials.gov
Contact:Principal Investigator: Sven Mobius-Winkler. Chefarzt der Medizinischen Klinik III/Kardiologie [Recruiting] Regensburg, Germany,
Stroke-Preventing Technology Demonstrated in JoVE
www.newswise.com
One major side-effect is the bleeding risk,” said paper author Dr. Sven Mobius-Winkler. “Therefore, only 50 percent of the patients who should ...
Stroke-preventing technology demonstrated in | EurekAlert!
www.eurekalert.org
· Sven Mobius-Winkler. “Therefore, only 50 percent of the patients who should take Warfarin actually take it.” The WATCHMAN device gives patients ...
sortiert nach Relevanz / Datum